Strumento inattivo

Azioni Advanced Cell Technology, Inc. OTC Bulletin Board

Azioni

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10/02/16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22/01/16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28/12/15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03/12/15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11/11/15

Dirigenti	Titolo	Età	Da
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03/02/15

Amministratori	Titolo	Età	Da
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+18,72%	123 Mrd
REGENERON PHARMACEUTICALS, INC.	+14,53%	107 Mrd
BIONTECH SE	-2,88%	24,01 Mrd
ARGENX SE	+2,18%	22,59 Mrd
GENMAB A/S	-10,09%	18,16 Mrd
WUXI APPTEC CO., LTD.	-41,04%	16,84 Mrd
BEIGENE, LTD.	-11,83%	16,23 Mrd
NEUROCRINE BIOSCIENCES, INC.	+1,46%	13,43 Mrd
SAREPTA THERAPEUTICS, INC.	+24,22%	11,32 Mrd